These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: a population-based study, 2004-2008. Sabo A; Tomić Z; Stilinović N; Milijašević B; Mikov M; Vukmirović S; Horvat O Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):45-9. PubMed ID: 20938914 [TBL] [Abstract][Full Text] [Related]
5. Assessing the clinical benefits of lipid-disorder drugs. Hiatt WR; Smith RJ N Engl J Med; 2014 Jan; 370(5):396-9. PubMed ID: 24476429 [No Abstract] [Full Text] [Related]
6. Ask the doctors. I have a high cholesterol level and my doctor started me on a statin. He has doubled the dose twice, but my levels are still high. What options do I have? Heart Advis; 2003 Mar; 6(3):8. PubMed ID: 12703458 [No Abstract] [Full Text] [Related]
7. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]]. Tomiyama H; Doba N Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101 [No Abstract] [Full Text] [Related]
8. Additional insights on how best to utilize statins. Feeman WE J Fam Pract; 2014 Mar; 63(3):128. PubMed ID: 24701605 [No Abstract] [Full Text] [Related]
12. Statin therapy: when to think twice. Wahawisan J; Tovar JM; Granberry MC J Fam Pract; 2013 Dec; 62(12):726-32. PubMed ID: 24340334 [No Abstract] [Full Text] [Related]
13. Fighting high cholesterol levels--lipid lowering drugs. Fidge NH Med J Aust; 1993 Dec 6-20; 159(11-12):815-9. PubMed ID: 8264477 [No Abstract] [Full Text] [Related]
14. Bezafibrate and simvastatin: different beneficial effects for different therapeutic aims. Tenenbaum A; Fisman EZ; Motro M J Clin Endocrinol Metab; 2004 Apr; 89(4):1978; author reply 1978-9. PubMed ID: 15070976 [No Abstract] [Full Text] [Related]
15. Economics of lipid lowering with HMG CoA reductase inhibitors. Illingworth DR Clin Cardiol; 1995 Jun; 18(6):295, 363. PubMed ID: 7664501 [No Abstract] [Full Text] [Related]
16. Simplifying the approach to the management of dyslipidemia. Gaziano JM; Gaziano TA JAMA; 2009 Nov; 302(19):2148-9. PubMed ID: 19920241 [No Abstract] [Full Text] [Related]
17. [Antilipemics: from prevention to protection]. Bordet R; Gelé P; Deplanque D; Duriez P Therapie; 2003; 58(1):69-76. PubMed ID: 12822203 [TBL] [Abstract][Full Text] [Related]
18. Niacin: old habits die hard. Haynes R; Rahimi K Heart; 2016 Feb; 102(3):170-1. PubMed ID: 26769376 [No Abstract] [Full Text] [Related]
19. Interactions between hypercholesterolemia and hypertension: implications for therapy. Borghi C Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):489-96. PubMed ID: 12187312 [TBL] [Abstract][Full Text] [Related]